WeightWatchers' CEO said on Wednesday it planned to offer Novo Nordisk's much-anticipated Wegovy in pill form if it is ...

By Jacob Gronholt-Pedersen and Stine Jacobsen COPENHAGEN (Reuters) -Newly-elected chairman of Wegovy-maker Novo Nordisk, Lars ...

Danish drugmaker Novo Nordisk said on Tuesday it had cut the price of its weight-loss drug, Wegovy, by up to 37% from its ...

Novo Nordisk’s oral therapy Wegovy (semaglutide) reduced cardiovascular risk factors in the Phase III OASIS 4 trial. Being ...

Novo Nordisk and Eli Lilly deny partnership with Mangoceuticals for weight-loss drugs, causing Mangoceuticals' shares to ...

The boardroom shake-up, which erupted when Novo's board Chair Helge Lund and the independent members stepped down last month ...

After [losing out to Pfizer]( ...

Shares of Novo Nordisk A/S (NYSE: NVO) dropped 1.9%today, closing at $48.25, just a whisker above the 52-week low of $45.05.

Hims & Hers continues to sell compounded semaglutide, the active ingredient in Novo’s Wegovy and Ozempic drugs, and these ...

Danish healthcare company Novo Nordisk has dropped prices for its weight-loss and diabetes drug Wegoy, the injectable ...

Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...